rapid
spread
coronaviru
infect
led
develop
molecular
serolog
test
short
period
time
test
rtpcr
applic
immedi
diagnosi
reveal
presenc
viru
serolog
test
use
determin
previou
exposur
viru
complement
acut
diagnosi
antibodi
product
occur
earli
day
postinfect
igm
igg
specif
antibodi
use
tool
test
faster
larger
group
individu
object
studi
carri
review
differ
serolog
test
offer
detect
antigen
antibodi
inform
use
decis
taker
differ
countri
choos
test
accord
need
base
web
page
list
serolog
assay
found
come
countri
major
indirect
test
specif
antibodi
detect
n
use
immunochromatographi
method
n
sampl
come
bloodderiv
product
n
measur
igmigg
time
n
procedur
time
min
n
common
overal
averag
sensit
specif
test
current
vitro
diagnosi
ivd
inform
gather
could
chang
day
day
due
expedit
process
product
emerg
author
use
nidovirus
positivesens
singlestrand
rna
virus
infect
larg
number
vertebr
within
famili
coronavirus
four
group
includ
betacoronaviru
caus
epidem
outbreak
recent
decad
although
coronavirus
describ
caus
common
respiratori
symptom
may
respons
uncompl
upper
respiratori
infect
sar
sever
acut
respiratori
syndrom
china
first
report
coronaviru
outbreak
mortal
around
viru
probabl
transmit
human
mammal
civet
cat
probabl
origin
deriv
bat
second
outbreak
mer
middl
east
respiratori
syndrom
origin
saudi
arabia
transmit
camel
also
origin
deriv
bat
mortal
close
third
epidem
coronaviru
cov
produc
coronaviru
diseas
began
wuhan
provinc
china
turn
pandem
sequenc
viru
genom
isol
patient
similar
bat
viru
china
infect
produc
mild
respiratori
symptom
infect
howev
admit
intens
care
unit
icu
receiv
mechan
ventil
mortal
rapid
case
growth
around
world
mean
short
time
health
system
scarc
resourc
icu
team
could
satur
rapidli
current
standard
assay
diagnosi
detect
viral
rna
use
rtpcr
nasopharyng
swab
rapid
simpl
immunoassay
test
develop
detect
antigen
igm
igg
antibodi
separ
simultan
viru
human
blood
even
within
minut
antibodi
respons
detect
earli
day
postinfect
antibodysecret
cell
peak
around
day
postinfect
one
first
peer
review
studi
kind
assay
show
test
sensit
specif
patient
confirm
pcr
current
immunoassay
detect
antigen
specif
antibodi
goal
studi
carri
comprehens
review
wide
offer
serolog
kit
detect
antigen
antibodi
order
help
institut
policymak
defin
best
option
possibl
massiv
test
urgent
need
rapid
serolog
test
use
tool
public
health
upcom
day
two
approach
use
literatur
search
web
search
page
list
serolog
test
pubm
http
wwwncbinlmnihgovpubm
peer
review
literatur
descript
inform
test
obtain
technic
data
sheet
td
respect
compani
web
page
variabl
obtain
countri
origin
type
immunoassay
procedur
time
sampl
type
fix
antigen
antibodi
isotyp
indirect
assay
sensibl
specif
current
regulatori
statu
publish
studi
use
report
nr
specifi
inform
variabl
found
na
variabl
appli
pubm
search
conduct
articl
describ
studi
serolog
human
sampl
keyword
use
human
serolog
either
ncov
human
antibodi
either
ncov
examin
articl
look
one
mention
use
commerci
antigen
antibodi
detect
kit
data
obtain
april
total
assay
report
intern
valid
defin
data
either
found
td
provid
manufactur
web
page
number
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
assay
report
sensit
specif
respect
sensit
test
rang
tabl
hand
specif
assay
rang
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
although
current
standard
amplif
viral
rna
rtpcr
techniqu
requir
special
equip
train
individu
also
detect
viru
depend
sampl
origin
time
sampl
detect
antiviru
specif
sarscov
antibodi
could
help
determin
exposur
larg
popul
viru
infect
individu
antibodi
detect
elisa
use
nucleocapsid
protein
antigen
identifi
initi
report
new
cov
caus
acut
respiratori
distress
syndrom
came
wuhan
china
sinc
sever
assay
develop
order
improv
diagnosi
china
expect
avail
test
detect
antibodi
use
bloodderiv
sampl
although
rtpcr
consid
sensit
detect
method
respiratori
fluid
sampl
increas
risk
contamin
healthcar
worker
bloodderiv
sampl
easier
obtain
compar
rtpcr
serolog
test
faster
requir
less
train
equip
use
almost
set
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
common
method
behind
later
flow
immunochromatographi
sinc
test
long
shelflif
requir
refriger
easili
distinguish
visual
result
exclud
need
addit
equip
compar
method
like
elisa
antigen
use
detect
import
genom
codifi
sever
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
protein
common
antigen
use
indirect
assay
recombin
spike
nucleocapsid
protein
protein
contain
domain
attach
human
host
cell
nucleocapsid
protein
one
major
structur
compon
involv
mani
process
viru
includ
viral
replic
transcript
assembl
interestingli
homolog
among
nucleocapsid
protein
show
homolog
coronaviru
isol
bat
test
assess
level
igg
igm
simultan
humor
respons
sarsassoci
coronaviru
show
simultan
increas
level
antibodi
also
dual
detect
iggigm
improv
sensibl
comparison
individu
igg
igm
antibodi
assay
suggest
possibl
improv
infect
detect
term
effici
shorter
procedur
time
mean
greater
evalu
capac
popul
test
specif
sensit
key
determin
role
assay
diagnosi
public
health
program
unfortun
minor
test
present
inform
mayb
due
short
time
develop
howev
present
sensit
specif
well
low
number
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
infect
individu
patient
rtpcr
confirm
viru
median
seroconvers
rate
igg
igm
time
depend
manner
day
diseas
onset
seroconvers
antibodi
isotyp
meanwhil
detect
rate
molecular
base
method
decreas
low
time
latter
show
specif
sensit
immunoassay
variabl
depend
time
onset
posit
result
given
later
time
diseas
onset
addit
differ
sampl
use
serolog
diagnosi
offer
consist
result
signific
differ
found
blood
serum
plasma
sampl
oppos
great
variabl
sampl
use
viral
rna
detect
sputum
nasooropharyng
swab
bronchoalveolar
lavag
rtpcr
antibodi
assay
advantag
howev
combin
provid
accuraci
initi
diagnosi
infect
moreov
current
label
requir
show
offer
assay
intend
invitro
diagnosi
applic
repres
use
clinic
environ
point
pandem
would
difficult
suggest
test
best
clinic
applic
howev
inform
present
shed
light
larg
number
assay
avail
number
increas
day
day
use
care
suggest
research
policymak
focu
one
inform
avail
rigor
intern
valid
data
well
defin
td
intend
use
invitro
diagnosi
research
need
especi
studi
compar
differ
test
provid
accur
inform
studi
singl
assay
yet
initi
data
look
promis
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
immunoassay
could
help
screen
larger
popul
less
time
increas
detect
rate
increas
test
capac
one
cornerston
need
decreas
spread
recent
studi
show
convalesc
patient
high
level
neutral
antibodi
nab
increas
patient
age
interestingli
transfus
convalesc
plasma
obtain
case
improv
clinic
outcom
patient
sever
diseas
thu
suggest
antibodi
produc
patient
infect
posterior
protect
effect
larg
serolog
studi
detect
virusspecif
antibodi
need
determin
infect
asymptomat
popul
also
could
help
suspend
social
isol
seroposit
individu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
